• Topics

  • COVID-19 and the liver
  • Public Health and Advocacy

Displaying results 13 - 24 of 48

Display:

12 24 48

Public Health and Advocacy

EASL Policy Dialogues S3 E7: Transforming Liver Health in Europe: Policy, Prevention, and Cancer Screening Initiatives

EASL Policy Dialogues

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - FR

PDF

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - GE

PDF

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - CZ

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - GE

PDF

View

Public Health and Advocacy

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - RU

PDF

View

Public Health and Advocacy

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - CZ

PDF

View

Public Health and Advocacy

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - EN

PDF

View

COVID-19 and the liver

EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Tr...

PDF

View

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - SP

PDF

View

Public Health and Advocacy

EASL Policy Statement on Screening of blood donations for hepatitis E virus (HEV)

PDF

View

Public Health and Advocacy

EASL Policy Statement on Reducing the burden of Alcohol Related Liver Disease (ARLD)

PDF

View

Displaying results 13 - 24 of 48

Display:

12 24 48